Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis
- PMID: 22668620
- DOI: 10.1016/j.oooo.2011.10.010
Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis
Abstract
Objective: The purpose of this study was to complete a systematic review and, if possible, a meta-analysis on the effectiveness of systemic and topical nucleoside antiviral agents in the prevention of recurrent herpes labialis (RHL) in immunocompetent subjects.
Study design: Multiple comprehensive electronic and manual literature searches without language restrictions identified the studies to be included. Quality assessment and data synthesis methods followed those described in the Cochrane guidelines.
Results: Of 2,683 papers reviewed, 10 met the inclusion criteria. Oral acyclovir (800-1,600 mg daily) and valacyclovir (500 mg daily for 4 months) were shown to be effective in the prevention of RHL when taken prior to the appearance of any symptoms or exposure to triggers. Of the 10 papers reviewed, only 1 was determined to have a low risk of bias.
Conclusions: This review found support for the use of systemic acyclovir and valacyclovir for the prevention of RHL.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment in
-
There is modest evidence that systemic acyclovir or valacyclovir prevents recurrent herpes labialis.J Evid Based Dent Pract. 2013 Mar;13(1):16-7. doi: 10.1016/j.jebdp.2013.01.004. J Evid Based Dent Pract. 2013. PMID: 23481008 No abstract available.
-
Systemic nucleoside antiviral agents may be effective in prevention of recurrent herpes labialis.Evid Based Dent. 2013;14(2):54. doi: 10.1038/sj.ebd.6400937. Evid Based Dent. 2013. PMID: 23792403
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous